{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "regularMarketChangePercent": -7.4257417, "regularMarketPrice": 0.935, "earningsTimestamp": 1683835520, "earningsTimestampStart": 1683835520, "earningsTimestampEnd": 1683835520, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.048, "sharesOutstanding": 37310100, "bookValue": 3.096, "fiftyDayAverage": 1.525728, "fiftyDayAverageChange": -0.590728, "fiftyDayAverageChangePercent": -0.3871778, "twoHundredDayAverage": 1.5860803, "twoHundredDayAverageChange": -0.6510803, "twoHundredDayAverageChangePercent": -0.41049644, "marketCap": 359832, "priceToBook": 0.30200258, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1538636400000, "priceHint": 4, "marketState": "POSTPOST", "exchange": "LSE", "shortName": "HOMOLOGY MEDICINES INC HOMOLOGY", "longName": "Homology Medicines, Inc.", "messageBoardId": "finmb_321461593", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "regularMarketChange": -0.07499999, "regularMarketTime": 1683699317, "regularMarketDayHigh": 0.0, "regularMarketDayRange": "0.0 - 0.0", "regularMarketDayLow": 0.0, "regularMarketVolume": 40000, "regularMarketPreviousClose": 1.01, "bid": 0.0, "ask": 0.0, "fullExchangeName": "LSE", "financialCurrency": "USD", "regularMarketOpen": 0.0, "averageDailyVolume3Month": 1977, "averageDailyVolume10Day": 1916, "fiftyTwoWeekLowChange": 0.935, "fiftyTwoWeekRange": "0.0 - 2.978", "fiftyTwoWeekHighChange": -2.043, "fiftyTwoWeekHighChangePercent": -0.6860309, "fiftyTwoWeekLow": 0.0, "fiftyTwoWeekHigh": 2.978, "symbol": "0T6G.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "One Patriots Park", "city": "Bedford", "state": "MA", "zip": "01730", "country": "United States", "phone": "781 301 7277", "website": "https://www.homologymedicines.com", "industry": "", "sector": "", "longBusinessSummary": "Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. The company's various set of AAVHSCs allows company to precisely target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, blood-brain-barrier, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II, as well as HMI-104 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.", "fullTimeEmployees": 92, "companyOfficers": [{"maxAge": 1, "name": "Dr. Albert  Seymour Ph.D.", "age": 54, "title": "CEO, Pres & Director", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 787054, "fmt": "787.05k", "longFmt": "787,054"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. W. Bradford Smith CPA, M.B.A.", "age": 66, "title": "CFO, Treasurer & Chief Bus. Officer", "yearBorn": 1956, "fiscalYear": 2022, "totalPay": {"raw": 720054, "fmt": "720.05k", "longFmt": "720,054"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 56640, "fmt": "56.64k", "longFmt": "56,640"}}, {"maxAge": 1, "name": "Dr. Paul  Alloway J.D., Ph.D.", "age": 51, "title": "Chief Legal Officer & Sec.", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 661451, "fmt": "661.45k", "longFmt": "661,451"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Saswati  Chatterjee Ph.D.", "title": "Co-Founder & Member of Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Theresa  McNeely", "age": 58, "title": "Chief Communications Officer & Patient Advocate", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Melissa  Gelormini", "title": "Sr. VP of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael  Blum M.B.A.", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Julie  Jordan M.D.", "age": 50, "title": "Chief Medical Officer", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Deborah  Kinch Ph.D.", "title": "Chief Devel. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}